A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph... | MicrobiomeTrials
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-07-30Est. Completion: 2026-12-31
Enrollment target: 60 participants
Locations
Children's Hospital of Los Angeles, Los Angeles, California, United States
Children's National Medical Center, Washington D.C., District of Columbia, United States
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Dana-Farber/Boston Children s Hospital, Boston, Massachusetts, United States
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States
Seattle Children's, University of Washington, Seattle, Washington, United States
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States